Suppr超能文献

[洋地黄毒苷的血象及氢氧化铝镁凝胶长期治疗时的肾脏排泄]

[Digitoxin blood picture and renal elimination in long-term therapy with aluminum-magnesium hydroxide gel].

作者信息

Kuhlmann J

出版信息

Dtsch Med Wochenschr. 1984 Jan 13;109(2):59-61. doi: 10.1055/s-2008-1069139.

Abstract

In ten patients in heart failure for which they were on long-term administration of digitoxin, the influence of aluminium-magnesium hydroxide gel (Maaloxan) on steady-state digitoxin plasma concentration and renal glycoside excretion was studied. Compared with control values before antacid medication (13.6 +/- 4.4 ng/ml), the administration of 20 ml aluminium-magnesium hydroxide gel three or four times daily for several weeks caused no significant change in digitoxin plasma levels (15.1 +/- 4.9 ng/ml). Daily renal glycoside excretion, as a further measure of bioavailability of digitoxin, was also unchanged by the antacid. Therapeutic plasma concentrations of digitoxin are not influenced by antacids which contain aluminium-magnesium hydroxide, at least not if the antacid is taken 1-2 hours after the digitoxin dose.

摘要

在10例因心力衰竭而长期服用洋地黄毒苷的患者中,研究了氢氧化铝镁凝胶(Maaloxan)对洋地黄毒苷稳态血药浓度及肾脏糖苷排泄的影响。与服用抗酸药前的对照值(13.6±4.4 ng/ml)相比,连续数周每天3或4次服用20 ml氢氧化铝镁凝胶后,洋地黄毒苷血药水平无显著变化(15.1±4.9 ng/ml)。作为洋地黄毒苷生物利用度的另一项指标,每日肾脏糖苷排泄量也未因抗酸药而改变。至少在洋地黄毒苷给药后1 - 2小时服用抗酸药的情况下,含氢氧化铝镁的抗酸药不会影响洋地黄毒苷的治疗血药浓度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验